
Dermatology Times' Monthly Crossword: August 2025
Key Takeaways
- The crossword puzzle integrates recent dermatology news, offering an engaging way to reinforce professional knowledge.
- Clues cover a range of topics, including treatment barriers, trial endpoints, and new products for various dermatological conditions.
Test your knowledge of key words and terms associated with dermatology news from the last month.
Welcome to Dermatology Times' Monthly Crossword, where dermatology knowledge meets fun! Each month, we curate a selection of words and terms pulled directly from the latest news in the dermatology world. Whether it's breakthrough treatments, new research findings, or emerging trends, this crossword serves as both a challenge and an opportunity to reinforce your expertise in the field.
For more in-depth insights, don't forget to check out our Weekly Roundup, where we break down the most important stories and updates from the past week. And to stay ahead of the curve and prepare for future crosswords, make sure to follow our content throughout the month.
Try out either our interactive crossword or a static/non-interactive version below.
Interactive Crossword
This crossword was created with CrosswordLabs.com .
Static/Non-Interactive Crossword
Across
3. barrier to care that often delays treatment initiation in hidradenitis suppurativa
4. Hair loss endpoint scored in alopecia trials
6. New sunscreen brand highlighted by Whitney Hovenic, MD, aimed at Gen Z
8. Pop icon who recently discussed a decades-long journey with psoriasis
10. Broad-band light therapy cornerstone for extensive/progressive vitiligo
11. FDA granted Fast Track to this IL-2 pathway biologic for severe alopecia areata
12. gene expression profile test that predicts metastasis and recurrence in high-risk cutaneous SCC
13. Access aid for eczema products discussed in AD safety piece
Down
1. JAK inhibitor showing ≥80% scalp regrowth in Phase 3 UP-AA
2. AbbVie biologic with UnlIMMited data in genital/scalp psoriasis
5. noninvasive sampling technique revealed immune signatures in seborrheic dermatitis
7. JAK-STAT inhibitor that shows promise for vitiligo and discoid lupus
9. Company moving an eczema therapy from case reports into clinical trials
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


















